Effect of nitric oxide and prostaglandins on renal function in insulin-resistant hypertensive dogs.
Martínez
F J
FJ
Department of Endocrinology, Hospital Ramón y Cajal, Madrid, Spain.
Villa
E
E
García-Robles
R
R
Romero
J C
JC
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D004195:Disease Models, Animal; D004231:Diuresis / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D005632:Fructose / Q000008:administration & dosage; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006973:Hypertension / Q000209:etiology / Q000503:physiopathology*; D007333:Insulin Resistance / Q000502:physiology*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D008469:Meclofenamic Acid / Q000494:pharmacology; D019331:NG-Nitroarginine Methyl Ester; D009318:Natriuresis / Q000187:drug effects / Q000502:physiology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology*; D011453:Prostaglandins / Q000502:physiology*; D012079:Renal Circulation / Q000187:drug effects / Q000502:physiology
D011453:Prostaglandins; D005632:Fructose; D009569:Nitric Oxide; D008469:Meclofenamic Acid; D001120:Arginine; D000109:Acetylcholine; D019331:NG-Nitroarginine Methyl Ester